Epigenetic mechanisms contribute to the establishment and maintenance of cell-type-specific gene expression patterns. In this review, we focus on the functions of histone lysine methylation in the context of epigenetic gene regulation during developmental transitions. Over the past few years, analysis of histone lysine methylation in active and repressive nuclear compartments and, more recently, genome-wide profiling of histone lysine methylation in different cell types have revealed correlations between particular modifications and the transcriptional status of genes. Identification of histone methyltransferases (HMTases) and specific binding factors for most methylated lysine positions has provided a novel insight into the mechanisms of epigenetic gene regulation. In addition, analyses of HMTase knockout mice show that histone lysine methylation has important functions for normal development. In this study, we review mechanisms of gene activation and repression by histone lysine methylation and discuss them in the context of the developmental roles of HMTases.
Introduction
Development is accomplished by spatial and temporal regulation of gene expression patterns. The identity of each cell type is maintained and passed on to daughter cells by mechanisms that do not alter the DNA sequence and are therefore regarded as epigenetic. A major mechanism to establish cell-type-specific expression patterns is transcriptional regulation. The physiological template for transcription is chromatin, and therefore epigenetic mechanisms are thought to modulate its structure, making DNA more or less accessible to the transcriptional machinery. Today, we know of five major mechanisms that alter chromatin architecture: DNA methylation, post-translational histone modifications, use of histone variants, chromatin remodeling and incorporation of non-coding RNA into chromatin. These mechanisms are generally considered 'epigenetic', although we still lack good understanding as to the stability of these modifications through mitosis or even through the germ line.
In this review, we will focus on the functions of histone lysine methylation during development. In the first part, we will discuss how histone lysine methylation facilitates gene activation or repression of genomic regions. In the context of these activities, we will then discuss the developmental roles of selected histone methyltransferases (HMTases).
Activation and repression are facilitated by histone lysine methylation
Major methylation sites on histones H3 and H4 are located in the tail (H3K4, H3K9, H3K27, H3K36 and H4K20) and the nucleosome core region (H3K79). Although histone methylation was discovered nearly four decades ago (Allfrey et al., 1964) , a correlation between this modification and gene regulation has only recently been established. Strahl et al. (1999) showed that H3K4 methylation was highly enriched in macronuclei of Tetrahymena, suggesting a role for this modification in transcriptional activation. A year later, H3K9 methylation was implicated in gene repression when a homolog of the heterochromatin-associated Drosophila Su(var)3-9, Suv39h1, was shown to have H3K9-specific methyltransferase activity (Rea et al., 2000) .
Lysine residues can be mono (me1), di (me2) or trimethylated (me3), and binding of specific proteins, which recognize methylated lysine positions, can result in different biological outcomes. The development of highly specific antibodies that discriminate not only between lysine positions, but also between methylation states, allowed the large-scale mapping of individual histone lysine methylation marks by chromatin immunoprecipitation on tiling arrays or chromatin immunoprecipitation followed by sequencing (reviewed in Lee and Mahadevan, 2009 ). In combination with gene expression data, correlations between histone modifications and gene activity have now been established. A number of modifications show some correlation with the transcriptional status of genes; however, only a very few marks are consistently found on active or inactive genes. The hallmark of transcriptionally active genes is H3K4me3 in the promoter region and H3K36me3 across the gene body ( Figure 1 ). H3K27me3 seems central for gene repression and covers the gene body and flanking regions (Figure 1 ). The average profile of repressed genes shows enrichment of H3K9me3 and H4K20me3 at a much lower level when compared with H3K27me3, suggesting that these marks are less important for gene silencing (Figure 1 ). In the next sections, we will discuss the current view of how active and repressive modifications are established and how they contribute to the transcriptional regulation of genes.
Histone lysine methylation marks in the context of transcriptional activation
The amount of transcript per cell is controlled through multiple mechanisms. If we only consider the rate of transcription, at least two major steps regulate how much primary transcript is produced. In the first step, RNA polymerase II (Pol II) is recruited to the promoter region and forms a pre-initiation complex (PIC). However, this is not sufficient for transcription, as RNA Pol II can be stalled at promoters and a second trigger is therefore required for elongation (Core and Lis, 2008) . Histone lysine methylation is an important regulatory element for both determining processes. It exerts an effect by recruiting specific binding factors, providing stable interaction platforms for the basic transcriptional machinery and for activities that regulate the ordered dis-and reassembly of chromatin during elongation.
Transcription initiation
Active genes carry high levels of H3K4me3 in the promoter region. This modification is a binding platform for a number of proteins (Table 1) , including chromatin remodelers, which help to open the chromatin structure around the promoter and facilitate the binding of the basic transcriptional machinery. BPTF (bromodomain PHD finger transcription factor), a subunit of the NURF (nucleosome remodeling factor) remodeling complex, and Chd1, another chromatin Figure 1 Profiles of histone lysine methylation at active and inactive mammalian genes. At active genes, H3K4me3 is highly enriched at the promoter region, whereas H3K36me3 associates with the gene body. At repressed genes, H3K27me3 covers the gene body and flanking regions. H3K9me3 and H4K20me3 are also enriched at inactive genes, although at a lower level (adapted from Barski et al., 2007 , Pauler et al., 2009 and Cui et al., 2009 . (Flanagan et al., 2005; Wysocka et al., 2006) . Although these data implicate chromatin remodeling in promoter activation, we still lack detailed mechanistic insight. Other binding proteins of H3K4me3 seem to be important for recognition of the promoter region. The TFIID complex is involved in the first step of PIC formation, and binds the promoter through multiple interactions between its subunits, DNA and histone modifications ( Figure 2 ). The TATA box binding protein (TBP) subunit, for example, and other associated proteins recognize the promoter DNA sequence. This can be either the TATA box itself or associated sequences, such as initiator and downstream promoter elements. The chromatin state is recognized by another TFIID subunit, the double bromodomain protein Taf1, which can bind acetylated lysines at positions H3K9 and H3K14 (Jacobson et al., 2000) . More recently, yet another TFIID component, the PHD domain protein Taf3, was shown to bind H3K4me3 (Vermeulen et al., 2007) . These data suggest that multiple interactions are necessary for stable recruitment of the PIC. The next step in the initiation cascade is binding of RNA Pol II to the promoter region and phosphorylation of Ser 5 in its carboxy-terminal domain (CTD) repeats by Cdk7. RNA Pol II is then able to generate short transcripts; however, interaction with DSIF (DRB sensitivity-inducing factor) and NELF (negative elongation factor) can inhibit elongation (reviewed in Fuda et al., 2009) .
Is H3K4me3 at the promoter a cause or a consequence of transcriptional activity? Currently, there is no general answer to this question and every promoter might behave somewhat differently. In vitro data suggest that this modification has no direct effect on transcription (Pavri et al., 2006; Kim and Buratowski, 2009 ); however, the reduced complexity of in vitro systems might mask an effect that is relevant in vivo. It is noteworthy that some inducible promoters carry H3K4me3 even before RNA Pol II is detectable, indicating that H3K4me3 can be established in the absence of active transcription (Edmunds et al., 2008) . Several enzymes can induce H3K4me3 (Table 2) , and elucidating how they are recruited and how their HMTase activity is regulated will be important in furthering our understanding of this modification. There is evidence that the CTD exerts an effect as a recruiting platform for different chromatinmodifying activities. For example, Mll1, a major H3K4-specific methyltransferase, interacts with the Ser 5 phosphorylated CTD and establishes or reinforces H3K4me3 around the promoter region (Milne et al., 2005) .
Transcription elongation
Binding to H3K4me3 might stabilize the PIC at the promoter and could therefore increase the probability of initiating transcription. The other mechanism to control the transcription rate is elongation (Figure 2 ). RNA Pol II can be stalled at promoters by interaction with NELF and DSIF. Elongation is then induced by phosphorylation of DSIF and RNA Pol II CTD at Ser 2 by the P-TEFb (positive transcription elongation factor b) complex (reviewed in Fuda et al., 2009) . For RNA Pol II to traverse nucleosomal templates, the chromatin structure needs to be relaxed. This is facilitated through eviction of H2A/ H2B dimers by the FACT complex (Belotserkovskaya and Reinberg, 2004) . After passage of RNA Pol II, the FACT complex could also be involved in the reassembly of a proper chromatin structure (Jamai et al., 2009) .
Several histone modifications are established when RNA Pol II travels through the gene body. The Ser 2 phosphorylated CTD associates with H3K36-specific Histone lysine methylation marks in the context of transcriptional activation. During initiation, TFIID is targeted to the promoter region through multiple interactions between its subunits and chromatin modifications (see text for details). RNA Pol II is positioned near the transcriptional start site and phosphorylated at Ser 5 of its CTD. The Mll1 complex binds to S5-P CTD and introduces H3K4me3 as well as acetylation of H4. Phosphorylation at Ser 2 of the CTD starts the elongation phase. The FACT complex disrupts nucleosomes in front of elongating RNA Pol II. Hypb binds to S2-P CTD and induces H3K36me3, which is recognized by Mrg15 leading to deacetylation of histones due to recruitment of histone deacetylases (HDACs).
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HMTases during elongation (Yoh et al., 2008) . H3K36me3 generates a binding platform for the chromo domain protein Mrg15 (Table 1, Zhang et al., 2006) , which in turn recruits histone deacetylases (Yochum and Ayer, 2002) . H3K36me3 and histone deacetylation are important to repress transcripts that could be generated from aberrant initiation of RNA Pol II within the gene body (Carrozza et al., 2005) . Thus, histone modifications in the context of elongation might indirectly affect the elongation rate and have important functions for re-establishment of a proper chromatin structure during and after transcription. Interestingly, recent data suggest that histone Spies et al., 2009) . These surprising connections between chromatin structure and RNA processing will reveal novel mechanisms for the regulation of cell-type-specific transcription profiles.
Repressive histone lysine methylation marks
Transcriptional repression is important for various aspects of development. On one hand, cell-type-specific expression patterns are regulated by silencing of lineageinappropriate genes during differentiation, and on the other hand, large regions of mammalian genomes consist of non-coding DNA sequences such as satellite repeats, telomeric repeats, mobile elements and interspersed repeats, which need to be under tight transcriptional control to prevent genomic instability. Genome-wide mapping studies of histone modifications consider only the nonrepetitive part of the genome and from these data it seems that H3K27me3 is a major modification that correlates with the transcriptional repression of genes ( Figure 1 ). In contrast, repetitive genomic regions are marked by H3K9me3 and H4K20me3. In the following sections, we will discuss the establishment and potential functions of repressive histone modifications at both highly repetitive genomic regions and at individual genes.
Silencing of repetitive genomic regions
Pericentric heterochromatin
The largest family of repetitive regions consists of major satellite repeats that are the main constituents of pericentric heterochromatin. Major satellite repeats have a distinct H3K9me3 þ H4K20me3 chromatin signature, which is found in almost all cell types and developmental stages, suggesting that these modifications have a general function in heterochromatin. H3K9me3 is established by Suv39h1 and Suv39h2 enzymes (Rea et al., 2000) . Two other HMTases, Suv4-20h1 and Suv4-20h2, establish H4K20me3 (Schotta et al., 2004) . Recent data suggest a novel modification, H3K64me3 that has a role in pericentric heterochromatin formation during the early stages of mouse development (Daujat et al., 2009) ; however, the responsible methyltransferase has not been identified as yet.
The combinatorial pattern of histone lysine methylation at heterochromatin is established in a sequential pathway (Figure 3) . In Schizosaccharomyces pombe, doublestranded RNA from centromeric repeats is processed by components of the RNA interference machinery. This leads to recruitment of Clr4, the S. pombe homolog of Suv39h, to establish H3K9 methylation at heterochromatin (Grewal and Jia, 2007) . In mammals, it is still unclear whether a similar link between processing of doublestranded RNA and recruitment of Suv39h exists. H3K9me3 is likely to be established in a highly coordinated manner during replication of pericentric heterochromatin. Recent data suggest that, in a first step, Setdb1 (SET domain bifurcated 1), in complex with heterochromatin protein 1a (HP1a) and CAF1 (chromatin assembly factor 1), induces H3K9me1 on non-nucleosomal histone H3 (Loyola et al., 2009) . Subsequently, Suv39h enzymes, which prefer H3K9me1 as substrate, induce H3K9me3, probably even before the H3 molecule is deposited into a nucleosomal context (Rea et al., 2000) . Nucleosomal H3K9me3 exerts an effect as a binding platform for HP1 proteins, which in turn recruit Suv4-20h enzymes to establish H4K20me3 (Schotta et al., 2004) . The direct interaction of Suv4-20h enzymes with HP1 is necessary to induce H4K20me3; however, interactions with other proteins, for example, members of the retinoblastoma family, can contribute to the establishment of this modification (Gonzalo et al., 2005) .
What are the functions of histone lysine methylation marks at pericentric heterochromatin? Although considered highly compact and transcriptionally silent, there is increasing evidence for controlled transcription across pericentric heterochromatin (Eymery et al., 2009) . Promoter elements are still unknown, and owing to the repetitive nature of these transcripts they have yet to be characterized. However, it is clear that transcription from major satellite repeats is tightly controlled, occurring only during distinct cell cycle stages. Suv39h double-null mutants show enhanced amounts of major satellite transcripts (Martens et al., 2005) , indicating that H3K9me3 has an important role in controlling the transcript levels from these repeat regions. How this control is accomplished, whether H3K9me3 or its binding factors hinder access to RNA Pol II or whether RNA processing or RNA stability are regulated by this modification are some challenging questions in this field. Figure 3 Repressive histone lysine methylation marks at heterochromatin are established in a sequential pathway. The Setdb1/ CAF1/HP1a complex presumably induces H3K9me1, which is converted to H3K9me3 by Suv39h enzymes. H3K9me3 exerts an effect as a binding platform for HP1 proteins, which in turn recruit Suv4-20h enzymes to induce H4K20me3. Establishment of these modifications is also regulated through interactions with other proteins, for example, members of the retinoblastoma (Rb) family. There is also evidence for interaction of DNA methyltransferases with Suv39h enzymes; however, this interplay needs further characterization.
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Telomeric silencing
The chromatin structure at telomeres is very similar to that of pericentric heterochromatin. Telomeric repeats are enriched for Suv39h-mediated H3K9me3. As in heterochromatin, H3K9me3 exerts an effect as a binding platform for HP1 proteins that recruit Suv4-20h enzymes to induce H4K20me3 (Benetti et al., 2007) . At telomeres, this sequential pathway is affected by the H3K79-specific HMTase Dot1l. It is noteworthy that Dot1l-mutant cells lose all H3K79 methylation and that at telomeres even H4K20me3 is lost . Currently, it is not known whether Dot1l or H3K79 methylation affects the activity or recruitment of Suv4-20h enzymes.
Transcripts from telomeric repeats (TelRNAs) are generated by RNA Pol II and are normally polyadenylated (Schoeftner and Blasco, 2008) . Interestingly, TelRNAs seem to be a structural constituent of telomeric chromatin. They can block telomerase activity, and therefore a possible function of these transcripts is the regulation of telomere length. In the absence of Suv39h or Suv4-20h enzymes, TelRNAs are upregulated, suggesting that H3K9me3 and H4K20me3 function as repressive modifications at telomeres (Schoeftner and Blasco, 2008) .
Gene silencing
Gene activation is largely correlated with the establishment of H3K4me3. In contrast, different modifications exist to mediate gene silencing. Average chromatin immunoprecipitation profiles across silenced genes suggest H3K27me3 as a prominent modification for gene repression ( Figure 1) ; however, there is also evidence that H3K9me3 and H4K20me3 are associated with repressed genes. Interestingly, different studies have found that there is a large proportion of silent genes that do not carry any of the tested epigenetic modifications. It is possible that these genes are passively repressed and that their silent state is just due to the lack of activating factors. However, we still lack knowledge about many histone modifications and their mechanisms of action, and it could well be that novel mechanisms for transcriptional silencing will be discovered in the near future. In the next sections, we will discuss how gene repression is established by the classic repressive histone modifications, H3K27me3 and H3K9me3.
Polycomb silencing by H3K27 methylation H3K27 methylation only exists in multicellular organisms and has probably evolved as a system to facilitate cell-type differentiation. Surprisingly, in embryonic stem (ES) cells, H3K27me3 can coexist in the same region with H3K4me3 (Bernstein et al., 2006a) . Genes that carry this 'bivalent' modification are mainly developmental regulators. Although bivalent genes are repressed, they carry engaged but stalled RNA Pol II. In differentiated cells, bivalent chromatin domains are reduced and genes that are active or repressed are characterized by H3K4me3 or H3K27me3, respectively (Mikkelsen et al., 2007) . It is not clear how bivalent marks are reduced to a univalent form during differentiation. One possibility is that during replication the bivalent modification cannot be 'copied' and either H3K4me3 or H3K27me3 is established on the newly replicated chromatin. Another postulation is that chromatin modifications at a particular gene reflect an equilibrium between antagonizing activities of transcriptional activators and repressors. Unequal cell division during differentiation of pluripotent progenitor cells might shift this balance to either side. Bivalent chromatin might also represent a transient state during differentiation. In ES cells, the major pluripotency genes Nanog, Sox2 and Oct4, are highly expressed and marked with H3K4me3. During differentiation, these genes transiently acquire a bivalent state before they become silenced with H3K27me3 (Pan et al., 2007) .
H3K27 methylation is mediated by the two highly related enzymes, Ezh1 (enhancer of zeste homolog 1) and Ezh2 (Table 2 ). Ezh enzymes form the so-called polycomb repressive complex 2 (PRC2) with Eed, Suz12 and RbAp46/48 proteins (Margueron et al., 2008) . It is noteworthy that ES cells in which PRC2 complex members such as Eed or Suz12, are disrupted, largely lose H3K27me2 and H3K27me3 (Schoeftner et al., 2006; Chamberlain et al., 2008) , suggesting that these proteins exert an effect as cofactors to fully stimulate enzymatic activity of Ezh enzymes.
H3K27me3 recruits the PRC1 complex (Ring1a/b, Bmi1, Ph, Cbx2) through interaction with the Cbx2 chromo domain (Figure 4 ). Other Cbx2 homologs bind H3K27me3 and can be part of PRC1-related complexes (Bernstein et al., 2006b) . For the recruitment of PRC1, binding to H3K27me3 is essential but probably not sufficient. This became clear through genome-wide mapping of PRC1 and PRC2 complexes (Ku et al., 2008) . Only a subset of regions with high levels of H3K27me3 also shows enrichment for PRC1 complex members. However, removal of H3K27me3 leads to complete loss of PRC1 from its targets (Cao et al., 2002; Leeb et al., 2010 ). An important function of PRC1 is the establishment of a second histone modification, H2A ubiquitylation on Figure 4 Polycomb-mediated gene silencing. Ezh1/2 enzymes, Suz12 and Eed, form the PRC2 core complex and induce H3K27me3. This modification is recognized by the chromo domain of mammalian Pc homologs, for example Cbx2, which is a subunit of the PRC1 complex. Ring1a/b, another PRC1 subunit, establishes H2AK119ub, which inhibits nucleosome disassembly by the FACT complex.
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The mechanism for transcriptional repression by the polycomb system (Figure 4) is still under debate. In vitro data suggest that PRC1 and PRC2 components can compact recombinant nucleosomes and block transcriptional elongation on chromatinized templates (Margueron et al., 2008); however, these mechanisms are very difficult to verify in vivo. A more compact chromatin structure might as well prevent promoter recognition by the PIC. Another intriguing finding is that H2AK119ub prevents recruitment of FACT (Zhou et al., 2008) , which could impair transcriptional elongation. These and maybe other epigenetic mechanisms, such as binding of non-coding RNAs and DNA methylation (Vire et al., 2006) , work together in the establishment of polycomb-mediated gene silencing. However, future studies are needed to dissect the interplay between these mechanisms.
Imprinting
Genomic imprinting is a well-characterized system that mainly uses epigenetic mechanisms to induce stable gene repression. Imprinted genes are only expressed from one allele; the other allele is permanently silenced using a heterochromatin-like mechanism. Silencing is established by repressive histone modifications and DNA methylation over so-called imprinting control regions (ICRs), which inhibit promoter activation or can block enhancer action.
Imprinted loci show allelic differences in epigenetic patterns. The ICR of the silenced allele carries heterochromatin-like modifications (H3K9me3 þ H4K20me3), whereas the active allele is marked with H3K4me3 (Fournier et al., 2002; Regha et al., 2007; Pannetier et al., 2008) . Not all imprinted genes are regulated in the same way, and in different developmental stages distinct mechanisms might be used to establish gene silencing. A surprising example is the discovery that imprinting in extraembryonic cells of the placenta uses a repression mechanism that mainly involves H3K27me3 (Lewis et al., 2004; Umlauf et al., 2004) .
Histone methylation at ICRs reflects the heterochromatic H3K9me3 þ H4K20me3 modification pattern; however, there are differences in the enzymatic systems and probably also in the recruitment mechanisms. In particular, the nature of the H3K9me3 HMTase in the context of imprinting is still somewhat unclear as Suv39h enzymes do not affect histone methylation at ICRs. Recently, another H3K9-specific HMTase, Setdb1, was found to associate with a particular imprinted region; however, no mechanistic studies have been performed to confirm a function of this enzyme in imprinting (Regha et al., 2007) . As in pericentric heterochromatin, H3K9me3 might serve as a binding platform for HP1 proteins, which can then recruit Suv4-20h enzymes to induce H4K20me3 at ICRs. In somatic cells, silencing of imprinted genes strongly depends on DNA methylation. We still do not know to what extent histone modifications contribute to silencing in this context. It could well be possible that histone methylation at ICRs functions downstream of DNA methylation (Henckel et al., 2009) . Histone methylation could also represent an additional layer of complexity to ensure stability of the repressed state.
Gene silencing by H3K9 methylation Average histone modification profiles across genes have revealed a weak correlation between H3K9me3 and gene repression ( Figure 1) ; however, as discussed above, imprinted genes are major targets of H3K9me3. There is also evidence that H3K9me3 is involved in repression of other genes, for example, nuclear receptor targets (Wissmann et al., 2007) . Importantly, a lower H3K9 methylation state, H3K9me2, might also have repressive functions. Differentiated cells carry large domains, up to several megabases long, with high levels of H3K9me2, and genes within these domains are repressed (Wen et al., 2009) .
In mammals, the different H3K9 methylation states are mediated by several enzymes (Table 2 ). H3K9me2 is mainly controlled by G9a and the related G9a-like protein (GLP), which function as heterodimers (Tachibana et al., 2005) . Suv39h1 and Suv39h2 induce H3K9me3 at heterochromatin. Little is known about the HMTases that are responsible for 'euchromatic' H3K9me3. The only good candidate for such an enzyme is Setdb1, which, as a recombinant enzyme, has poor activity. However, association with the auxiliary factor mAM confers H3K9me3 activity to this enzyme (Wang et al., 2003) . Setdb1 is an important functional constituent of the Kap1 corepressor complex that mainly uses H3K9me3 as a means of gene repression (Sripathy et al., 2006) . To what extent Setdb1 is really responsible for H3K9me3 in vivo remains to be tested.
Different histone methylation states are thought to confer distinct functions. For H3K9 methylation, it is still unclear whether di-or trimethyl states are functionally distinct. The best characterized binding protein, HP1 (Table 1) , has affinity to both H3K9me2 and H3K9me3 in vitro (Lachner et al., 2001) . H3K9 methylation seems to be crucial for HP1 recruitment and binding to heterochromatin, as Suv39h-mutant cells that lose H3K9me3 also lose HP1 from heterochromatin (Lachner et al., 2001) . It is also very likely, however, that additional factors can stabilize the binding of HP1 at H3K9me2/3 targets. How silencing is then facilitated by H3K9 methylation is still unclear. The current model suggests that HP1 binding induces a higher grade of chromatin compaction, which would prevent access of transcription factors or RNA Pol II to DNA.
Developmental functions of HMTases
In the previous sections, we discussed functions of histone lysine methylation marks in gene activation and repression, but how important are these mechanisms for normal development? Over the past few years, knockout mice for several HMTases have been established and characterized. In the following sections, we will summarize these data and discuss the functional implications of histone lysine methylation for cell-type identity and regulation of developmental transitions.
Gene activation by H3K4 methylation
Activation of genes often correlates with H3K4me3 at the promoter region. It is not really clear whether H3K4me3 is a consequence of RNA Pol II recruitment or whether this modification represents a poised state for genes that can be easily activated. The major enzymes that induce (Table 2) . Mll proteins are regarded as important regulators of development as homologous proteins in Drosophila (trithorax) positively regulate expression of homeotic genes. This function is conserved in mammals and disruption of individual Mll genes in mice leads to reduced expression of Hox genes and developmental defects, as will be outlined below.
Mll1 was the first Mll family member to be functionally analyzed in mice. Dependent on the knockout strategy, Mll1 disruption results in different phenotypes. Truncation of Mll1 in exon 3b or deletion of exons 9-11 both lead to embryonic lethality between E12.5 and E16.5 (Yu et al., 1995; Yagi et al., 1998) . Even heterozygous Mll1 þ /À knockout mice show defects in segment identity that are caused by reduced expression of distinct Hox genes (Hoxa-9 and Hoxc-7).
A very powerful model system to analyze development and differentiation is the hematopoietic system with well-defined stem cells, progenitor populations and differentiated cells. It is noteworthy that Mll1 À/À embryos fail to generate or expand hematopoietic stem cells during embryogenesis (Ernst et al., 2004) , and, consistent with these data, conditional inactivation of Mll1 in adult mice also disrupts the hematopoietic stem cell compartment (Jude et al., 2007; McMahon et al., 2007) . Although the mechanism is not clear, it seems plausible that impaired Hox gene regulation might contribute to these defects in the hematopoietic system (Lawrence et al., 2005) .
To understand the function of Mll1-mediated H3K4me3, another allele was generated that deletes the SET domain region (Terranova et al., 2006) . In contrast to all other Mll1 knockout alleles, DSET mutants are fully viable and show only slight homeotic transformations. However, in DSET mutants, expression of distinct Hox genes is also reduced (Hoxd-4 and Hoxc-8), indicating that the methyltransferase activity of Mll1 is important for gene activation. On the other hand, the relatively mild phenotype of DSET and the only modest downregulation of Hox genes suggest compensatory mechanisms that allow a rather normal development of these mutants.
Mll1 deficiency does not impair overall H3K4 methylation as several other H3K4-specific methyltransferases exist in mice that can compensate for the loss of Mll1 (Table 2) . Three other Mll family members have been disrupted in mice (Mll2, Mll3 and Mll5). These mutants show different phenotypes, suggesting different targets or functions. Mll2 À/À mice are growth retarded and show embryonic lethality around E11.5 (Glaser et al., 2006) . In mutant embryos and ES cell lines, a higher apoptosis rate might be caused by downregulation of the anti-apoptotic factor Bcl2 (Lubitz et al., 2007) . In Mll2 À/À ES cells, very few genes are misregulated, suggesting that Mll2 has very few unique targets in this cell type (Glaser et al., 2009) . One target gene, Magoh2, which is downregulated in Mll2 À/À ES cells, loses H3K4me3 at the promoter region. Interestingly, there is a concomitant increase in H3K27me3, indicating that chromatin modifications at Mll target genes are negotiated between antagonizing activities of the Mll group HMTases and Ezh enzymes.
Mll3 and Mll4 are present in complexes that share the PTIP (Pax transactivation domain-interacting protein) subunit, which is not present in Mll1 or Mll2 complexes (Cho et al., 2007) . The difference in complex composition might also regulate targeting to distinct sets of genes. Mll3/4 have no apparent effect on Hox gene expression. Instead, they regulate H3K4 methylation at targets of the nuclear hormone receptors, retinoic acid receptor and peroxisome proliferator-activated receptor-g (Lee et al., , 2008a . Mll3-mutant mice are viable and do not show severe patterning defects; however, differentiation to distinct lineages, for example, adipocytes, is partially impaired, indicating an important function of Mll3 for normal development (Lee et al., 2008a) .
Mll5 was regarded as inactive for a long time as no methyltransferase activity of the recombinant protein could be detected. A recent study has since shown that Mll5 is a histone H3K4-specific methyltransferase whose activity critically depends on GlcNacylation of Threonin 440 (Fujiki et al., 2009) . Mll5 knockout mice are born at Mendelian ratios; only a few pups die during the first days postpartum. These data indicate that there are no severe developmental defects associated with loss of Mll5; however, closer inspection of the surviving mutants revealed that hematopoietic development is impaired and, in particular, the function of hematopoietic stem cells is reduced (Heuser et al., 2009; Madan et al., 2009; Zhang et al., 2009) .
The enzymatic system for H3K4 methylation in mammals is highly complex. Mll proteins are a part of large complexes with common components and distinct interaction partners. Mll1 and Mll2 complexes share the common Menin subunit. Single Mll1 or Mll2 mutants impair H3K4 methylation at only a subset of Hox genes. Disruption of Menin has a much stronger effect and almost all H3K4 methylation is lost from Hox loci (Wang et al., 2009) . Much less is known about targets of the other H3K4 HMTases. Although Mll3-5 induce only some H3K4 methylation outside of the Hox loci, Setd1a/ Setd1b HMTases have major roles in global H3K4 methylation (Wu et al., 2008) . These enzymes are a part of multi-subunit complexes, most similar to the yeast COMPASS complex, and probably have a very general function in transcriptional activation. We expect that knockouts for these enzymes will generate severe defects, maybe even at the cellular level.
Repression of developmental regulators by H3K27 methylation
A classical model system for developmental gene regulation is the regulation of Hox gene expression. In Drosophila, the major players that determine transcriptional activity of distinct Hox genes are components of the activating trithorax and the repressive polycomb system, which are primarily recruited to specific DNA sequences (polycomb response elements). The founding member of the PcG family in Drosophila is polycomb, a chromo domain-containing protein whose targeting depends on H3K27me3 by E(z) (Cao et al., 2002) . In mammals, many PcG components are conserved; however, the primary targeting mechanism is still unclear, as no polycomb response elements have been identified as yet.
In mice, there are two H3K27-specific HMTases, Ezh1 and Ezh2 (Table 2) . Interestingly, their expression Epigenetic regulation of development S Dambacher et al patterns differ as Ezh2 is predominantly expressed in undifferentiated/proliferating cells, whereas Ezh1 is more abundant on terminal differentiation (Margueron et al., 2008; Ezhkova et al., 2009) .
H3K27 methylation correlates with gene repression and is enriched at repressed Hox genes and in female mammals at the inactive X chromosome. Thus, deregulation of Ezh enzymes in mice is expected to generate strong phenotypes by affecting the gene activity of important developmental regulators. Indeed, Ezh2 knockout mice show early embryonic lethality around E8.5 . Ezh2 knockout ES cells can be established and selectively lose H3K27me2 and H3K27me3 while maintaining H3K27me1. Interestingly, at some important developmental genes, H3K27me3 is preserved in Ezh2 À/À ES cells , indicating that Ezh1 and Ezh2 share partially redundant functions.
To analyze the function of H3K27me3 for developmental transitions, conditional Ezh2 knockout mice were established (Su et al., 2003) . During B cell development, Ezh2 is highly expressed in early progenitor populations (pro-B and pre-B cells), whereas Ezh1 is only expressed in late stages. Inactivation of Ezh2 in the hematopoietic lineage blocks the transition from pro-B to pre-B cells; however, later stages of B cell development are not impaired (Su et al., 2003) . In this model system, transcriptional deregulation has not been investigated and the reason for the developmental block at the pro-B cell stage might be the improper processing of antigen receptor rearrangements.
Ezh2 deletion was also analyzed in skin development, in which basal layer progenitor stages can be distinguished from suprabasal cells that have initiated the program of terminal differentiation. Again, expression of Ezh2 is highest in the progenitor population and decreases with differentiation stage (Ezhkova et al., 2009) . Deletion of Ezh2 in developing skin leads to dramatic loss of H3K27me3, resulting in accelerated epidermal differentiation and precocious acquisition of the epidermal barrier. Gene expression analysis of wild-type versus Ezh2-deleted epidermal precursor cells revealed that although H3K27me3 was almost lost in these cells, only approximately 90 genes were deregulated (mostly upregulated). Most of these genes are normally expressed in the final stages of epidermal development. The premature activation of the terminal differentiation program in the absence of Ezh2 suggests that transcriptional activators for epidermal differentiation are already present in the progenitor stages and that H3K27me3 blocks their access to target promoters (Ezhkova et al., 2009) . Most other genes, which also lose H3K27me3 in the absence of Ezh2, are not activated, suggesting that they are repressed by different mechanisms or that appropriate transcriptional activators are not expressed in this tissue. The question as to how H3K27me3 can block the binding of transcription factors has not been addressed. The intriguing possibility that specific binders of H3K27me3, for example, Cbx2 in the context of the PRC1 complex, mediate compaction of the chromatin structure should be tested in future studies.
We think that H3K27me3 has a major role for developmental transitions ( Figure 5) . In pluripotent cells, developmental regulators are repressed by the bivalent modifications H3K27me3 and H3K4me3. After lineage decision, these genes are either active and carry H3K4me3 or they are inactive and show enriched signals for H3K27me3. Apparently, in committed progenitor cells there are at least two categories of H3K27me3-repressed genes. One category is lineage-appropriate genes that need to be activated in later stages of differentiation. Full activation of these genes depends on removal of H3K27me3, probably by histone demethylases (Agger et al., 2007; Lan et al., 2007) that would then allow binding of transcriptional activators. Lineage-inappropriate genes, the second category, need to be stably repressed by H3K27me3 together with other mechanisms, such as different histone methylation marks or DNA methylation. Aberrant activation of lineage-inappropriate genes might as well be prevented by the lack of transcriptional activators. More detailed analyses are required to distinguish between these possibilities.
Repression of repetitive elements and gene regulation by H3K9 methylation
The first H3K9-specific methyltransferases that were disrupted in mice were the Suv39h1 and Suv39h2 (Peters et al., 2001) . Single mutants do not show obvious defects, possibly due to compensatory effects. Surprisingly, even Suv39h double mutants are viable, although they show some prenatal lethality during embryogenesis. In Suv39h double-null cells, H3K9me3 is lost from heterochromatin; however, total H3K9me3 levels are only reduced by approximately 50%. Suv39h mainly regulates repetitive regions, such as major satellite repeats and transposons (Martens et al., 2005) , as no target genes of Suv39h enzymes could be identified as yet. Alterations in the chromatin structure across repetitive elements can have drastic effects on overall genome stability. It is noteworthy that Suv39h doublenull fibroblasts show increased chromosome segregation defects, indicating that centromere function is impaired. Genomic instability could also contribute to tumor development and sterility, which was observed in Suv39h-mutant mice (Peters et al., 2001) . These findings show that H3K9me3 has important functions for genomic integrity by repression of mobile elements, thereby ensuring normal development and long-term survival.
Another H3K9-specific HMTase, Setdb1, has been suggested to induce H3K9me3 for gene repression. Setdb1 knockout mice show a strong phenotype with peri-implantation lethality between days E3.5 and E5.5. The defects are so severe that not even embryonic stem cell lines could be established from null mutant blastocysts (Dodge et al., 2004) , the reason for which is not understood. Setdb1-mediated H3K9me3 might have important roles in later developmental transitions by regulating targets of transcription factors (Yang et al., 2002) and nuclear hormone receptors (Takada et al., 2007) . In a very elegant study, Takada et al. (2007) show that in mesenchymal cells of the bone marrow, noncanonical Wnt signaling induces phosphorylation of Setdb1, which leads to the formation of a corepressor complex with peroxisome proliferator-activated receptor-g. Repression of peroxisome proliferator-activated receptor-g targets by H3K9me3 drives differentiation of mesenchymal stem cells into the osteoblastic lineage. Catalytically inactive Setdb1 mutants could not ensure repression of peroxisome proliferator-activated receptorg targets, leading to differentiation of the mesenchymal cells into adipocytes. These findings show that H3K9me3-mediated gene repression is extremely important to establish transcriptional programs during lineage decisions. Conditional inactivation of Setdb1 in different tissues will surely reveal additional implications of this essential HMTase for normal development.
H3K9me2 is a mainly euchromatic modification that is controlled by G9a and GLP HMTases (Table 2 ). G9a knockout mice show severe defects during embryogenesis, leading to developmental delay and lethality around day E9.5 (Tachibana et al., 2002) . Unlike Suv39h1 and Suv39h2 that work redundantly to induce H3K9me3 at heterochromatin, heterodimer formation between G9a and GLP is essential to establish H3K9me2. Thus, GLP mutant embryos show defects that are almost identical to the G9a knockout, and double inactivation of G9a and GLP does not cause stronger phenotypes (Tachibana et al., 2005) .
G9a-mutant ES cells show only little transcriptional deregulation and only one target gene, Mage-2a, has been shown as a direct target (Tachibana et al., 2002) . Interestingly, G9a-mediated H3K9 methylation has important functions during the differentiation of ES cells through the stable inactivation of approximately 120 genes, including the pluripotency genes Oct4 and Nanog (Feldman et al., 2006; Epsztejn-Litman et al., 2008) . Stability of silencing is ensured through DNA methylation by Dnmt3a/b, which directly interacts with G9a (Epsztejn-Litman et al., 2008) .
G9a mediates H3K9 methylation in another developmentally important context: genomic imprinting. In extraembryonic tissues, imprinting of the Kcnq1 domain is not dependent on DNA methylation, but the ICR shows high levels of H3K9me2 and H3K9me3. It is noteworthy that G9a mutants lose parental-specific imprinting of the Kcnq1 region selectively in the extraembryonic tissue through loss of H3K9me2 and H3K9me3 (Wagschal et al., 2008) . Although the average enrichment of H3K9 methylation states across silenced genes (Figure 1) has not suggested major roles for this modification in gene regulation, the abovementioned examples show that both H3K9me2 and H3K9me3 have important functions for gene silencing and for the regulation of developmental transitions.
Concluding remarks
The functional analysis of different HMTases in the context of knockout mouse models has revealed that histone lysine methylation has important roles in facilitating normal development; however, there are still many open questions. Knockout mice for only approximately 50% of mouse HMTases have been generated and analyzed (Table 2) , and for many of these proteins we do not even know their enzymatic activity. Several HMTase mutants show early embryonic lethality with pleiotropic defects. A more detailed functional analysis in different tissues is required to better understand their functional implications in developmental processes. The paper by Ezhkova et al. (2009) is a very appropriate example for such an analysis.
How are different histone lysine methylation marks interpreted? Are different methylation states really functionally distinct? We only know binding proteins for a subset of positions and methylation states (Table 1) . In vitro, most binders analyzed so far show only weak affinity to their targets, and the different methylation states cannot be clearly distinguished. Are there other mechanisms in vivo that could increase the affinity to their targets?
Epigenetic gene regulation has become a very complex field. In this review, we have only covered the functions of histone lysine methylation in transcriptional regulation; however, there is interplay and dependency between many different epigenetic mechanisms. Chromatin remodelers, for example, recognize histone modifications and can also mediate the exchange of histone variants (Konev et al., 2007) . Non-coding RNAs are able to recruit histone-modifying activities that ultimately alter the transcriptional status of targets (Nagano et al., 2008) . Histone modifications can be established in sequential pathways in which one modification recruits specific binders and these proteins, in turn, recruit other modifying activities (Schotta et al., 2004) . The future challenge in epigenetic research will be to understand this complex network of regulatory mechanisms.
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